Gut Microbiome Signatures Distinguish Susceptibility from Disease Development in Type 2 Diabetes

Area of Science:

• Microbiology
• Metabolic Diseases
• Genetics

Background:

• Individual susceptibility to type 2 diabetes involves genetic and environmental factors.
• The gut microbiome's role in diabetes susceptibility is not fully understood.
• Distinct microbial signatures may modulate sensitivity or resistance to diabetogenic diets.

Purpose of the Study:

• To investigate if gut microbial composition contributes to diabetes susceptibility, separate from disease development.
• To test the hypothesis that distinct microbial signatures influence sensitivity or resistance to a diabetogenic diet (DD).

Main Methods:

• Studied Cohen diabetic rat model (diabetes-sensitive CDs/y and diabetes-resistant CDr/y strains).
• Analyzed fecal microbial composition using 16S rRNA gene sequencing and diversity measures.
• Performed co-housing experiments for microbial cross-transfer and assessed diabetic phenotypes.

Main Results:

• Distinct, strain-specific gut microbiota profiles were found in diabetes-sensitive versus -resistant rats.
• Co-housing led to microbial community convergence and attenuated diabetes in sensitive rats, supporting a causal role.
• Separate microbial taxonomic signatures differentiated diabetic from non-diabetic animals.

Conclusions:

• The gut microbiome plays a contributory and causal role in modulating diabetes susceptibility.
• Distinct microbial pathways are involved in diabetes susceptibility versus disease development.
• The gut microbiome represents a modifiable determinant of diabetes risk and a potential target for early intervention.